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Abstract: Severe early childhood caries (S-ECC) affects 17% of 2-3 year old children in South Australia impacting on 
their general health and well-being. S-ECC is largely preventable by providing mothers with anticipatory guidance. Ran-
domised controlled trials (RCTs) are the most decisive way to test this, but that approach suffers from near inevitable loss 
to follow-up that occurs with preventative strategies and distant outcome assessment. 
We re-examined the results of an RCT to prevent S-ECC using sensitivity analyses and multiple imputation to test differ-
ent assumptions about violation of random allocation (1%) and major loss to follow-up (32%). Irrespective of any as-
sumptions about missing outcomes, providing expectant mothers with anticipatory guidance during pregnancy and in the 
child’s first year of life, significantly reduced the incidence of S-ECC at 20 months of age. However, the relative risk of 
S-ECC varied from 0.18 (95% confidence interval (CI): 0.06 – 0.52) to 0.70 (95% CI: 0.56 – 0.88). Also the ‘number 
needed to treat’ (NNT) to prevent one case of S-ECC varied 2.5-fold: from 8 to 20 women given anticipatory guidance. 
Multiple imputation provided a best estimate of 0.25 (95% CI: 0.11 – 0.56) for the relative risk and of 14 (95% CI: 10 – 
33) for the number needed to treat. 
Avoiding loss to follow-up is crucial in any RCT, but is difficult with preventative health care strategies. Instead of aban-
doning randomisation in such circumstances, sensitivity analyses and multiple imputation can consolidate the findings of 
an RCT and add extra value to the conclusions derived from it. 
Key Words: Health promotion, early childhood caries, randomized controlled trial, multiple imputation, intention-to-treat, 
number needed to treat, sensitivity analysis, pregnancy, Zelen design. 
INTRODUCTION 
Severe early childhood caries (S-ECC) is an important 
public health problem. The US National Institutes of Health 
defined S-ECC as the presence of one or more missing, filled 
or decayed tooth surfaces, whether cavitated or not, in a 
child below 3 years of age [1]. If left untreated, it severely 
affects a child’s general health, learning ability and quality 
of life and can have a life-long impact on oral health [2, 3]. 
Children who experience caries as infants or toddlers have a 
much greater probability of further caries in their primary 
and secondary dentitions [3]. In the 1990s, the prevalence of 
S-ECC among 2-3 years olds in South Australia was 16.7% 
[4]. As such children are entirely dependent on the care pro-
vided by others, mothers and other childcarers need oral 
health programs to support them in preventing S-ECC, while 
communities need to know what does and does not work in 
S-ECC prevention [5]. To address this issue we conducted a 
randomised controlled trial (RCT) of anticipatory guidance 
[6] targeting first time mothers [7].  
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While RCTs are generally considered as the “gold stan-
dard” for obtaining solid evidence on the effect of health 
care interventions, some have questioned their applicability 
to complex interventions [8] and to health promotion strate-
gies in particular [9-11]. The latter tend to be complex and 
require a long follow-up that may exceed the attention span 
of participants, who do not have a problem in the first place. 
Attrition bias (literally referring to ‘wearing out’) as people 
loose interest or are lost for one reason or another, may de-
feat the whole object of random allocation. This becomes 
especially problematic when retention rates and loss to fol-
low-up differ substantially between the randomised groups 
[12-14].  
Another, more general problem arises from people’s per-
ception that what is new must be better, thereby limiting 
their willingness to be randomly assigned to what is per-
ceived as the lesser of the strategies compared. Limited par-
ticipation will inevitably affect the generalisability of the 
findings to people outside the actual participants. Zelen [15] 
described an approach to address this. In it, potential partici-
pants are randomised to the proposed study arms before con-
sent is sought and consent is then sought only from those 
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criticized by ethicists on several grounds, mostly relating to 
people’s right to know and to the fallacy of assuming that 
people in the control group would also have consented, if 
they had been aware of the alternative option [16-18].  
These objections are largely overcome in a Zelen design 
with double consent [19]. In the double consent design, po-
tential participants are still randomised before consent. 
Thereafter, they are informed about their group allocation, 
given full information on the alternative interventions and 
offered the choice of either accepting or rejecting the random 
allocation and of moving to the opposite group, if they 
choose to do so. As the most unbiased assessment is between 
the groups as allocated [19], irrespective of whether they 
received the intervention or not, based on the “intention-to-
treat principle” (ITT) [20], there are two major drawbacks to 
this approach. The first is a loss of statistical power, if many 
participants refuse the allocation, and the second is a loss of 
difference between the groups as randomised, when partici-
pants move from one group to the other.  
In this paper, we address the consequences of the double 
consent form, but especially the attrition bias inherent in 
studies with prolonged follow-up, using sensitivity analysis 
and multiple imputation. To do so, we have used the data of 
our RCT “Cavity free children” in which the intervention 
targeted pregnant women expecting their first child, while 
the outcome was the oral health of their child at 20 months 
of age [7]. We address two questions that are relevant to 
similar studies conducted elsewhere. First, to what extent did 
the change of subjects from their allocated group influence 
the results? Second, how would the results change, if all en-
rolled subjects had participated until the end of the study 
without loss to follow-up?  
MATERIALS AND METHODS 
In 2002, we started an RCT to assess an oral health pro-
motion intervention “Cavity free children”, targeting preg-
nant women expecting their first child. Recruitment occurred 
with ethical approval at all five public maternity units in 
Adelaide during routine antenatal visits [7]. Zelen’s design 
with double consent [19] was used to allocate women to the 
intervention and control groups. The intervention consisted 
of providing expectant mothers with printed information on 
oral health and early childhood caries, which was reinforced 
with additional information, sent by mail when the child was 
6 months and 12 months old, focusing on the child’s needs at 
that age [6]. Outcome assessment was the presence of any 
carious lesion on the upper incisors, assessed by dental ex-
amination at 20 months of age. The trial resulted in a signifi-
cant difference in the occurrence of S-ECC between the in-
tervention and control infants (1.7% versus 9.6%; p <0.01) 
[7].  
However, of 649 women allocated to the intervention and 
control groups, only 441 (68%) brought their child for a den-
tal examination to assess outcome at 20 months of age [7]. 
Twenty-four had been legitimately excluded for pre-
specified reasons, unrelated to their allocation and all due to 
legitimate absence of a mother-infant pair because of miscar-
riage, stillbirth, infant death, congenital malformations, child 
in the custody of Child and Youth Services, or mother in 
custody. Fifteen were in the intervention group and nine in 
the control group. A further 184 participants were lost to 
follow-up: 32 had moved to a distant locality, 66 were not 
traceable, and 86 failed to attend for dental examination for 
reasons, such as a new pregnancy, conditions of employ-
ment, problems with the child’s health or with transport, or 
declining further participation.  
The comparability of the groups was evaluated at base-
line and again for those attending dental examinations to 
assess whether loss to follow-up had distorted the compara-
bility of groups. Baseline characteristics assessed were vari-
ous demographic factors (e.g. age, ethnicity, marital status, 
occupation, level of education) and women’s perception of 
their general and dental health and oral hygiene [7]. The 
same characteristics and the child’s age at tooth eruption 
were compared for those completing follow-up. There were 
no statistically significant differences between the interven-
tion and control groups at baseline and at follow-up. While 
this suggests that the difference in S-ECC between the inter-
vention and control groups is entirely attributable to the ef-
fect of the intervention, many would consider a loss to fol-
low-up of 32% unacceptably high for an RCT [14]. We, 
therefore, conducted sensitivity analyses and multiple impu-
tation as an approach to consolidate its findings.  
Sensitivity analyses basically assess how robust the re-
sults are to changes in how the study was done. In other 
words, to what extent do different assumptions about the 
people, who were randomised but not included in the out-
come assessment, affect the outcome. To do so, we tested the 
assumptions that those lost to follow-up would all have had 
S-ECC, no S-ECC, or the same incidence of S-ECC as those 
retained in the intervention group, the control group or over-
all.  
We also conducted multivariable imputation, a simula-
tion-based approach originally designed for complex sur-
veys, in which several important data may be missing for 
variable proportions of participants [21, 22]. It addresses the 
fact that analyses including only participants with complete 
data may not yield valid inferences about the entire study 
population [22]. It is based on the statistical principle that 
every subject in a random sample can be replaced by another 
subject, randomly drawn from the same sample as the origi-
nal subject, without compromising the conclusions. Missing 
values for each subject are filled in (imputed) with values 
predicted from the rest of the subject’s known characteris-
tics. A random component is added to the imputed value to 
account for the uncertainty due to the imputed value not be-
ing observed, but estimated. This is done by creating not one 
but several (multiple) imputed data sets, which are analysed 
separately and later combined to provide estimates and co-
variance matrices [23]. Multivariable techniques, employing 
a sequence of regression models, are used for imputing miss-
ing values [23].  
In our analysis, the estimates were calculated using IVE-
ware [23]. Outcome data were imputed for each participant 
lost to follow-up, conditional on the known variables for that 
participant, considering imputation on a variable by variable 
basis [23]. The basic strategy was to create imputations 
through sequences of multiple regressions, each time over-
writing previously drawn values, building interdependence 
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putations were used to create the data set. The independent 
variables used in the regression model to predict the inci-
dence of S-ECC were maternal age, gestational age at en-
rolment and at the time of birth, the mother’s body mass in-
dex and her self-reported decayed, missing or filled teeth 
(DMFT). Information on each of these was available for 
more than 97.5% of enrolled women (missing data: range: 0-
14, mean: 5.2; 0.8%).  
SPSS 15.0 for Windows, IVEware and Revman 4.2 were 
used for data analysis.  
RESULTS 
Effects of the Zelen Double Consent Design 
Bias, resulting from non-acceptance of the allocation, ap-
plied to only five mothers who opted for the intervention 
group after having been assigned to the control group. As 
none of their infants experienced S-ECC, their small number 
marginally affected only the denominators and not the nu-
merators without changing the number needed to treat 
(NNT) to prevent one case of S-ECC (Table 1).  
Effects of Loss to Follow-up  
The assumptions that infants without follow-up would all 
have S-ECC or would all not have S-ECC, both confirmed 
the statistically significant effect of the anticipatory guidance 
(Table 2). However, the relative risk and absolute risk reduc-
tion (i.e. risk difference) changed markedly, resulting in a 
2.5 times difference in the NNT from 8 to 20. The more real-
istic approach of considering that those lost to follow-up 
would follow the overall pattern or that of their own or their 
opposite group resulted in marked differences in relative 
risk, but had little effect on the NNT, ranging between 17 
and 20 (Table 2).  
The multiple imputation approach (Table 2) affected the 
relative risk compared with both the intention to treat analy-
sis and the analysis based on infants available for outcome 
Table 1. Effect of Cross-Over Between the Intervention and the Control Group (Zelen’s Double Consent Design) and Loss to Follow-
Up on the Effectiveness of an Early Childhood Caries Prevention Programme 
S-ECC Observed (n/N) *  Outcome Parameters (95% Confidence Interval) 
Type of Analysis 
Intervention  Control  Relative Risk  Risk Difference  NNT ** 
Analysis for all participants recruited irrespective of their pregnancy outcome and presence or absence of a mother-infant pair 
Primary intention to treat analysis  4/322  20/327  0.20  (0.07 - 0.59)  0.05  (0.02 - 0.08)  20  (13 - 50) 
Analysis for all mother-infant pairs in the study 
Intention to treat analysis  4/307  20/318  0.21  (0.07 - 0.60)  0.05  (0.02 - 0.08)  20  (13 - 50) 
Analysis per treatment received  4/312  20/313  0.20  (0.07 - 0.58)  0.05  (0.02 - 0.08)  20  (13 - 50) 
Analysis for mother-infant pairs with outcome assessment 
Analyses per group allocation  4/227  20/214  0.19  (0.36 - 0.52)  0.09  (0.03 - 0.12)  11  (8 - 33) 
Analysis per treatment received  4/232  20/209  0.18  (0.06 - 0.52)  0.08  (0.04 - 0.12)  13  (8 - 25) 
* S-ECC = severe early childhood caries  
** Number Needed to Treat to prevent one case of S-ECC. It is calculated as (1/Risk Difference) 
Table 2. Effect of Different Assumptions About Missing Outcome Data on the Effectiveness of an Early Childhood Caries Prevention 
Programme 
Number with S-ECC*  Outcome Parameters (95% Confidence Interval) 
Assumptions About Missing Outcomes 
Intervention Control  Relative Risk  Risk Difference  NNT ** 
All lost to follow-up have S-ECC  84  124  0.70  (0.56 - 0.88)  0.12  (0.04 - 0.19)  8  (5 - 25) 
None lost to follow-up have S-ECC  4  20  0.21  (0.07 - 0.60)  0.05  (0.02 - 0.08)  20  (13 - 50) 
All have S-ECC frequency as intervention 
group 
5  22  0.24  (0.09 - 0.61)  0.05  (0.02 - 0.08)  20  (13 - 50) 
All have S-ECC frequency as control group  12  30  0.41  (0.22 - 0.79)  0.06  (0.02 - 0.09)  17  (11 - 50) 
All have S-ECC frequency as entire popu-
lation 
8  26  0.32  (0.15 - 0.69)  0.06  (0.02 - 0.09)  17  (11 - 50) 
Multiple imputation of missing outcomes  7  29  0.25  (0.11 - 0.56)  0.07  (0.03 - 0.10)  14  (10 - 33) 
* Cases of severe early childhood caries (S-ECC) that would have been observed in the intervention (n = 307) and control group (n = 318) with mother-infant 
pair as randomised, if the assumption about missing outcomes would be correct. 
** Number Needed to Treat to prevent one case of S-ECC. 58    The Open Dentistry Journal, 2010, Volume 4  Plutzer et al. 
assessment (Table 1), but the risk difference and, conse-
quently, the NNT of 14 was nearly identical to that calcu-
lated on the basis of the available follow-up data (NNT = 
13).  
DISCUSSION 
Over the years RCTs have attracted friends and foes. 
This is likely to continue as not everything can be evaluated 
in this way [11]. RCTs are formally planned, prospective 
studies to compare the effects of an intervention with those 
obtained by alternative approaches. Randomisation, analo-
gous to a fair coin toss, is the key word in this type of study 
as it is the only known means of ensuring that every partici-
pant, irrespective of her or his prior characteristics, has an 
equal chance of being assigned to one intervention or an-
other [13]. Proper conduct of an RCT is governed by several 
further requirements, including a clearly formulated protocol 
with stated conditions for inclusion and exclusion of subjects 
and prior calculation of the number needed to minimize the 
likelihood that the results will reflect the play of chance [13, 
20]. While these elements are all essential to the interpreta-
tion and meaning of the findings, the real benefit of an RCT 
arises from whether its findings are likely to be applicable to 
others, both patients and clinicians, outside the trial.  
The two crucial issues of ‘are the results an unbiased as-
sessment of the intervention studied’ and ‘are the results 
applicable to other people than those in the trial’ are com-
monly referred to in the literature respectively as internal and 
external validity [25]. The latter is often referred too as ‘gen-
eralisability’ [25]. In the field of health promotion, these two 
issues are more intertwined than in any other field. If the 
results are seriously biased, there is no need to know about 
them. If they are unbiased, but cannot be generalised to a 
substantial part of the population, their usefulness for en-
hancing population health is likely to be minimal.  
In our RCT, we dealt with these issues using a strict pro-
tocol with inclusion and exclusion criteria, validated out-
come measures and prior power analysis [7]. We recruited 
women at all public maternity units in Adelaide. By compar-
ing the characteristics of our participants with those of all 
women giving birth in Adelaide [26], we could ascertain that 
these women were a ‘random sample’ of first time mothers 
attending for public antenatal care. The results may not be 
generalisable to the 35% of women seeking private maternity 
care, as these tend to be older, of higher socio-economic 
status and more likely to be Caucasian than women attending 
public hospitals [26]. Our concern, however, was to ensure 
that the results would be applicable to the majority of first 
time mothers and their infants in the public health system. 
Our exclusion criteria, based on the fact that not every preg-
nant woman will have a child nearly two years down the 
track, were also explicit and stringent. We could not control, 
however, for women opting out, choosing the alternative 
approach, lost to follow-up, or declining further participation 
for one reason or another. While our choice for a Zelen de-
sign was based on the need to enhance participation and to 
obtain a representative sample of the population, the current 
in-depth analysis was prompted by the substantial and un-
avoidable loss to follow-up.  
Zelen’s original design [15], intended to address issues of 
validity, is rightly rejected by most ethicists [16, 17], as it 
results from an era in which people’s need for full informa-
tion about alternative options and responsibility for their own 
health were not given the same attention as they are today. In 
its double consent form, Zelen’s design [19] largely over-
comes such objections and substantially enhances the gener-
alisability of the conclusions that can be derived from a sin-
gle trial. The findings are more likely to be applicable to the 
population concerned than those of a trial in which few eli-
gible persons have sufficient equipoise to accept chance al-
location. This would seem to be particularly important with 
preventative strategies. Firstly, there is often some refusal to 
participate in preventative actions, which the Zelen design 
can account for. Secondly, contamination of the control 
group, whose members wittingly or unwittingly acquire 
some of the exposure that should have been restricted only to 
those in the intervention group, can be a major problem in 
such trials. This problem, also referred to as ‘contamination 
bias’ or ‘dilution bias’ [27], is largely avoided by offering 
participants a genuine choice of moving from one group to 
the other, if they desire to do so.  
Cross-over from one group to another is a major concern, 
however, as groups that were comparable at the time of ran-
domisation may no longer be comparable at the time of out-
come assessment based on the actual treatment received. 
Analyses based on the ‘intention to treat’ (ITT) principle, the 
accepted standard for all RCTs [12, 20], cannot resolve this 
either when treatments have become effectively ‘homoge-
nised’ [17, 19]. Adamson et al. [27], who identified 58 trials 
that had used a Zelen design between 1990 and 2005, found 
a mean cross-over rate of 13.8%. Even with the single con-
sent design, a cross-over rate of only 10% requires a 20% 
increase in sample size to maintain power [19]. With a 10% 
cross-over in the double consent design, sample size needs to 
increase with 60% in order to achieve the power of a conven-
tional RCT [19, 27]. Fortunately, cross-over was a minor 
issue in our trial, occurring in less than 1% and being uni-
directional, only from the control group to the intervention 
group. As no cases of S-ECC were observed in the few par-
ticipants who changed group allocation, adjustment of the 
outcome statistics affected only the denominators and not the 
numerators. This may not be so in other trials, however, and 
emphasises the need for sensitivity analyses when interpret-
ing the results of such trials. 
Loss to follow-up is a major issue in any RCT addressing 
outcomes that are not immediate. After all, its major strength 
is in the ITT principle, analysing results irrespective of what 
happens after randomisation [13, 20] or, as others have put 
it, ‘once randomised, always analysed’ [14]. In health pro-
motion interventions, which target healthy people and distant 
outcomes, this is a genuine nightmare. Efforts to track all 
participants for as long as is needed, however intensive, are 
bound to fail as people pursue other objectives in life. Sensi-
tivity analyses in general and multiple imputation techniques 
in particular, imperfect as they are, provide an answer to this. 
They have not been given much attention, however [12, 28]. 
For example, the extensive glossary of the Cochrane Col-
laboration on terms and definitions related to RCTs 
(http://www.cochrane.org/resources/glossary.htm) does not 
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Frequent as loss to follow-up is, there is no consensus on 
how to deal with it in an RCT, other than that every effort 
should be made to reduce losses to the absolute minimum 
[12-14, 28]. This is more readily achieved when the interval 
between intervention and outcome is short, when targeting 
people dependent on ongoing care, and when there is ongo-
ing contact between investigators and participants. None of 
this applied to our trial, as the protocol stipulated absence of 
any contact with the control group between informed consent 
and outcome assessment, about two years later, in order to 
mimic the real life situation.  
Some consider that the results of RCTs with substantial 
loss to follow-up should be disregarded, but it is arbitrary 
what percentage should be considered as substantial [14]. 
When only a minority of people experience the outcome of 
interest, any loss to follow-up that exceeds the frequency of 
that outcome has the potential of creating a two-fold differ-
ence between what was observed and what could have been 
observed, if there had been no loss to follow-up. To avoid 
this issue, some have chosen intermediate outcomes, that are 
more readily available, as surrogates for what really matters 
[29, 30]. Not infrequently, intermediate outcomes have led to 
conclusions that could not be upheld by more substantive 
assessments later on [30, 31]. It has also led to different in-
terpretations of what is meant by the ITT principle [12, 32]. 
Generally, little attention has been given to other means of 
testing the robustness of the findings.  
Our most simple sensitivity analyses, assuming all possi-
ble outcomes for the missing mothers and infants random-
ised, as shown in Table 2, confirmed and added strength to 
the conclusion that anticipatory guidance can reduce the 
prevalence of S-ECC [7]. In its least favourable or “worst 
case” scenario, providing anticipatory guidance would still 
benefit 5% of the population, as one case of S-ECC would be 
prevented for every 20 pregnant women provided with such 
guidance. More often than not, however, the “worst case” 
scenario will provide results that are of little relevance to 
practice. Even if there are only a moderate number of miss-
ing outcomes, assuming all missing values to be good or bad 
is too strong an assumption to give a reasonable estimate of 
the effect of an intervention [33]. Moreover, such analyses 
can easily provide inconsistent or even contradictory results 
[12], leaving little option but to disregard the data. 
While, for our trial, these simple analyses demonstrate 
the robustness of the findings to any assumptions made 
about missing outcomes, this is still of little value when peo-
ple want to know not only whether something works, but 
also how much it works. Where resources are limited, num-
bers needed to treat that differ 2.5-fold are not particularly 
helpful. Multiple imputation, whilst not replacing the need 
for complete data, provides a far more reasonable approach 
to the problem. Apart from a more balanced appraisal of the 
validity of a trial, when there are differences between people 
randomised and those with outcome assessment, it also pro-
vides a more realistic estimate of what can be expected when 
the intervention is applied to a similar population elsewhere. 
Obviously, it will be helpful mainly if it incorporates vari-
ables that are shown to be predictive of attrition bias and loss 
to follow-up [33].  
In conclusion, although evaluating preventative strategies 
and oral health promotion programmes in particular by 
means of RCTs is fraught with difficulties [9, 10], this is not 
a reason to abandon RCTs when seeking solutions to impor-
tant health issues. Despite their difficulties, RCTs remain at 
the top of all known methods for evaluating whether some-
thing works or not. Neither do we advocate that sensitivity 
analyses and multiple imputation techniques provide an ade-
quate alternative to complete follow-up of all subjects ran-
domised. However, RCTs and multiple imputation are not 
goals by themselves. They are merely tools in the quest of 
what is and what is not effective in health care. Every tool 
has its limitations and, as every dentist knows, few compli-
cated tasks are ever accomplished with only a single tool.  
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